Drug‐induced Autoimmune Myasthenia Gravis a

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Annals of the New York Academy of Sciences

• Publication date

  1998-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1749-6632.1998.tb10961.xPMID 9668273
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Induction of auto-immune syndromes by penicillamine therapy in rheumatoid arthritis and other diseases

  2005cited by this paper
• Immunogenicity and immunopathogenicity of an autoimmune epitope are potentiated by increasing MHC binding through residue substitution.

  1997cited by this paper
• Effects of the quinoline derivatives quinine, quinidine, and chloroquine on neuromuscular transmission.

  1996cited by this paper
• Conversion of low antibody responders into high responders by up-regulating the T cell response to a selective epitope.

  1996cited by this paper
• Coexistent membranous nephropathy and ANCA-positive crescentic glomerulonephritis in association with penicillamine.

  1996cited by this paper
• D-penicillamine-induced autoantibodies in a mouse model.

  1995cited by this paper
• Adverse Effects of Monobactams and Carbapenems

  1995cited by this paper
• D‐penicillamine‐ and quinidine‐induced antinuclear antibodies in A.SW (H‐2s) mice: similarities with autoantibodies in spontaneous and heavy metal‐induced autoimmunity

  1994cited by this paper
• Effects of D‐Penicillamine on Multiple Immunogenic Epitopes of the Acetylcholine Receptor a

  1993cited by this paper
• Cells from Mice Exposed Chronically to D‐Penicillamine Show Proliferative Responses to D‐Penicillamine‐Treated Self (Macrophage/Dendritic Cells): A Graft‐versus‐Host Response? a

  1993cited by this paper
• D-penicillamine induced myasthenia gravis: clinical, serological and genetic findings.

  1993cited by this paper
• A T-cell response to the anti-arthritic drug penicillamine in the mouse: requirements for generation of the drug-derived antigen.

  1992cited by this paper
• Frequent induction of insulin autoantibodies by D-penicillamine in patients with rheumatoid arthritis.

  1992cited by this paper
• Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen

  1992cited by this paper
• Drug-induced pemphigus: autoantibodies directed against the pemphigus antigen complexes are present in penicillamine and captopril-induced pemphigus.

  1991cited by this paper
• Augmented IgG anti-acetylcholine receptor response following chronic penicillamine administration.

  1991cited by this paper
• D-penicillamine-induced autoimmunity in Brown-Norway rats. Similarities with HgCl2-induced autoimmunity.

  1990cited by this paper
• Fine antigenic specificities of antibodies in sera from patients with D-penicillamine-induced myasthenia gravis.

  1988cited by this paper
• Genetic control of delayed-type hypersensitivity to D-penicillamine antigen.

  1988cited by this paper
• Drug-protein conjugates--XV. A study of the disposition of D-penicillamine in the rat and its relationship to immunogenicity.

  1988cited by this paper
• Seronegative myasthenia gravis

  1988cited by this paper
• Immunity to D-penicillamine: genetic, cellular, and chemical requirements for induction of popliteal lymph node enlargement in the mouse.

  1987cited by this paper
• A single 10-residue pre-S(1) peptide can prime T cell help for antibody production to multiple epitopes within the pre-S(1), pre-S(2), and S regions of HBsAg.

  1987cited by this paper
• A specific enzyme-linked immunosorbent assay for definition of the IgG antibody response to disulphide-conjugated D-penicillamine in the rabbit.

  1987cited by this paper
• The pathophysiology of penicillamine‐induced myasthenia gravis

  1986cited by this paper
• The induction of human antinuclear antibodies by D-penicillamine: activation of inducer helper T cells in the absence of irradiation sensitive suppressor T cells.

  1986cited by this paper
• Specific sensitization of Lyt-1+2- T cells to spleen cells modified by the drug D-penicillamine or a stereoisomer.

  1986cited by this paper
• Adverse effects profile of sulfhydryl compounds in man.

  1986cited by this paper
• Acetylcholine receptor binding site contains a disulfide cross-link between adjacent half-cystinyl residues.

  1986cited by this paper
• Demystifying the Japanese miracle

  1985cited by this paper
• Drug-protein conjugates--IX. Immunogenicity of captopril-protein conjugates.

  1985cited by this paper
• Effects of prolonged administration of D-penicillamine or captopril in various strains of rats. Brown Norway rats treated with D-penicillamine develop autoantibodies, circulating immune complexes, and disseminated intravascular coagulation.

  1984cited by this paper
• Augmented anti—acetylcholine receptor response following long‐term penicillamine administration

  1984cited by this paper
• D-penicillamine-induced myasthenia gravis in primary biliary cirrhosis.

  1984cited by this paper
• HLA antigens and acetylcholine receptor antibodies in penicillamine induced myasthenia gravis.

  1983cited by this paper
• Penicillamine‐induced myasthenia gravis

  1982cited by this paper
• Anti-idiotypic route to anti-acetylcholine receptor antibodies and experimental myasthenia gravis.

  1982cited by this paper
• STUDIES ON THE PATHOPHYSIOLOGY OF CHRONIC D‐PENICILLAMINE‐INDUCED MYASTHENIA *

  1981cited by this paper
• Neuromuscular transmission and acetylcholine receptor antibodies in rheumatoid arthritis patients on D-penicillamine.

  1980cited by this paper
• Structural stabilization of isolated acetylcholine receptor: specific interaction with phospholipids.

  1979cited by this paper
• Protein thiolation and reversible protein-protein conjugation. N-Succinimidyl 3-(2-pyridyldithio)propionate, a new heterobifunctional reagent.

  1978cited by this paper
• ANTIBODIES TO ACETYLCHOLINE RECEPTORS IN RABBITS: IMMUNOCHEMICAL AND ELECTROPHYSIOLOGICAL STUDIES *

  1976cited by this paper
• Immune responses in vitro. I. Culture conditions for antibody synthesis.

  1972cited by this paper
• Myasthenia gravis syndrome associated with trimethadione.

  1970cited by this paper
• Association of trimethadione therapy and myasthenia gravis.

  1966cited by this paper
• The Use of N-Formylamino Acids in Peptide Synthesis

  1958cited by this paper
• A New Mixed Disulphide: Penicillamine–Cysteine

  1954cited by this paper

• Pathophysiological basis in the management of myasthenia gravis: a mini review

  2022cites this paper
• Drug-Induced Disorders of the Nervous System

  2021cites this paper
• Pathomechanisms and Clinical Implications of Myasthenic Syndromes Exacerbated and Induced by Medical Treatments

  2020cites this paper
• Management and resolution of acquired myasthenia gravis in a carbimazole-treated hyperthyroid domestic shorthair cat

  2019cites this paper
• Identifying the culprits in neurological autoimmune diseases

  2019cites this paper
• Myasthenia Gravis: paradox versus paradigm in autoimmunity.

  2014cites this paper
• Diagnosis and management of myasthenia gravis

  2014cites this paper
• Neuromuscular Junction Disorders due to Systemic Disease

  2013cites this paper
• Etiology of myasthenia gravis: innate immunity signature in pathological thymus.

  2013cites this paper
• An Uncommon Presentation of Myasthenia Gravis with Thymoma - A Case Report and Review of Literature

  2012cites this paper
• The etiology of autoimmune diseases: the case of myasthenia gravis

  2012cites this paper
• Immune response in human pathology: hypersensitivity and autoimmunity

  2011cites this paper
• Acetylcholine Receptor-Induced Experimental Myasthenia Gravis: What Have We Learned from Animal Models After Three Decades?

  2011cites this paper
• Neuromuscular junction toxicity with tandutinib induces a myasthenic-like syndrome

  2011cites this paper
• Severe muscular weakness as an isolated symptom of azathioprine hypersensitivity.

  2011cites this paper
• Clinical applications of immunomics

  2009cites this paper
• Myasthenia gravis associated with etanercept therapy

  2009cites this paper
• Sudden dysphagia in an elderly , quadriparetic patient § Dysphagie soudaine chez un patient âgé tétraparétique

  2009cites this paper
• Sudden dysphagia in an elderly, quadriparetic patient.

  2009cites this paper
• Myasthenia gravis precipitated by trauma: latent myasthenia and the concept of 'threshold'.

  2009cites this paper
• Third cranial nerve palsy or pseudo 3rd nerve palsy of myasthenia gravis? A challenging diagnosis in systemic lupus erythematosus

  2009cites this paper
• Emerging Therapies for the Treatment of Autoimmune Myasthenia Gravis

  2009cites this paper
• Clinical features of myasthenia gravis.

  2008cites this paper
• NEUROLOGIC COMPLICATIONS OF SJÖGREN SYNDROME AND RHEUMATOID ARTHRITIS

  2008cites this paper
• The immunopathogenesis of myasthenia gravis.

  2008cites this paper
• Statins may aggravate myasthenia gravis

  2008cites this paper
• A review of myasthenia gravis: Pathogenesis, clinical features and treatment

  2007cites this paper
• Myasthenia gravis and scleroderma: two cases and a review of the literature.

  2007cites this paper
• Interleukine-6 (IL-6) may be a link between myasthenia gravis and myoepithelioma of the parotid gland.

  2007cites this paper
• Diagnosis and treatment of myasthenia gravis.

  2007cites this paper
• Case report Myasthenia gravis and scleroderma: Two cases and a review of the literature

  2007cites this paper
• Severe muscular weakness: an unusual adverse effect of azathioprine therapy.

  2006cites this paper
• CD8-positive T cell-induced liver damage was found in a patient with polymyositis.

  2006cites this paper
• Immunotoxicology

  2005cites this paper
• Increasing incidence of late-onset anti–AChR antibody–seropositive myasthenia gravis

  2005cites this paper
• Principles of immunopharmacology

  2005cites this paper
• Update on myasthenia gravis

  2004cites this paper
• Acetylcholine Receptor Structure

  2003cites this paper
• Acetylcholine receptors and myasthenia

  2000cites this paper
• Risk factors for acquired myasthenia gravis in cats: 105 cases (1986-1998).

  2000cites this paper